Life & LuxuryHealth & WellnessCardiovascular healthGina KolataSep 9, 2026 – 5.00amNovartis has announced that its experimental drug pelacarsen, widely assumed to be the vanguard of a new era in preventing heart attacks, strokes and cardiovascular deaths, has failed.The announcement gave no further details, but it came as a shock to the field of cardiology.Subscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? Latest In Health & wellnessFetching latest articlesMost Viewed In Life and luxury